ArticleNeurology. Genetics2025
Genotype-Phenotype Association for 14
Article in Neurology. Genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Synergistic Effects of Glial Fibrillary Acidic Protein Mutation and Overexpression in the Pathogenesis of Alexander Disease.International journal of molecular sciences · 2026Article
- Alexander disease mutations differentially sensitize glial fibrillary acidic protein (GFAP) to posttranslational modifications and network disruption by oxidants.Redox biology · 2026Article
- Erratum: Genotype-Phenotype Association for 14Neurology. Genetics · 2025Article
Corrections and comments
- Erratum issued
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objectives: Alexander disease is a rare monogenic disorder caused by dominant variants in Methods: We compiled a list of variants in Results: Fourteen variants met our criteria for detailed analysis (10 with 7 or more unrelated cases and 4 additional variants involving 2 of the most commonly affected amino acids, R79 and R239) derived from a total of 231 cases. The variants seem to fall into 3 distinct groups-some with consistent early onsets (N77S, R79C and R79L, and most of the R239s), some with consistent late onsets (R70W and N386S), and some with more variable onsets (R416W). Pairwise comparison results found that R239H was associated with significantly earlier onsets than R239C. We found similar groupings for survival. Finally, we evaluated sex as a potential modifying factor for either age at onset or survival but found no significant association. Discussion: Genotype-phenotype correlations do exist in Alexander disease, at least for a limited number of GFAP variants for which sufficient numbers of individual cases can be identified to allow valid statistical analysis.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.